Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Screening for Osteoporosis in General Practice

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02220699
Recruitment Status : Completed
First Posted : August 20, 2014
Last Update Posted : July 19, 2016
Sponsor:
Collaborator:
Aalborg University Hospital
Information provided by (Responsible Party):
Martin Bach Jensen, Aalborg University

Brief Summary:
All Danish general practices have a data capture system that collects selected data from the electronic patient record. These data are used for various quality assurance purposes. The aim of the study is to evaluate the quality assurance system/program that identifies patients having an increased risk of osteoporosis.

Condition or disease
Osteoporosis

Show Show detailed description

Layout table for study information
Study Type : Observational
Actual Enrollment : 367 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Screening for Osteoporosis in General Practice. Identifying Patients With Osteoporosis in General Practice by Using the Program Data Capture
Study Start Date : January 2014
Actual Primary Completion Date : November 2014
Actual Study Completion Date : May 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Osteoporosis




Primary Outcome Measures :
  1. Number of patients with osteoporosis [ Time Frame: 6 weeks after visit at the GP clinic ]
    Participating patients are referred to a bone mineral density measurement (DXA scan). The exact time depends on the waiting time for bone mineral density Measurements.


Secondary Outcome Measures :
  1. Number of patients with osteopenia [ Time Frame: 6 weeks after visit at the GP clinic ]
    At the time of bone mineral density measurement

  2. Cost of identifying a patient with osteoporosis [ Time Frame: 2 weeks after bone mineral density measurment ]
    The total cost from inviting the patients until the patients have finished all examinations, except blood testing for secondary osteoporosis (but not including expenses after treatment for osteoporosis may have begun)


Other Outcome Measures:
  1. Patients satisfaction with being contacted to participate in a osteoporosis prevention study [ Time Frame: baseline ]
    Assessed by questionnaire



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   25 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients at list at the participating general pracitices who are identified to be at an increased risk of osteoporosis by the data capture program are invited to participate (by direct contact, mail or e-mail)
Criteria

Inclusion Criteria:

  • Patient identified as being at an increased risk of osteoporosis by the data capture system

Exclusion Criteria:

  • Known osteoporosis.
  • Patients treated with alendronate.
  • Patients below 25 years of age.
  • Bone metastasis.
  • Terminal disease.
  • Severe dementia or other disease or condition that is incompatible with participation.
  • Bone mineral density scan within the past 3 years.
  • Errors in their ICPC coding that leads to the patient being misclassified as having an increased risk of osteoporosis.
  • Patients not wanting to participate.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02220699


Locations
Layout table for location information
Denmark
Lægerne Sløjfen (a family medicine clinic)
Aalborg, North Denmark Region, Denmark, 9220
Sponsors and Collaborators
Aalborg University
Aalborg University Hospital
Layout table for additonal information
Responsible Party: Martin Bach Jensen, GP, Ph.D, Professor at Department of Clinical Medicin, Aalborg University and head of the Research Unit of General Practice in Aalborg, Aalborg University
ClinicalTrials.gov Identifier: NCT02220699    
Other Study ID Numbers: FEA-RN-2014-1
First Posted: August 20, 2014    Key Record Dates
Last Update Posted: July 19, 2016
Last Verified: July 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Martin Bach Jensen, Aalborg University:
Ostoporosis
Primary Prevention
Health Promotion
General Practice
Secondary screening
Patients at increased risk of osteoporosis
Additional relevant MeSH terms:
Layout table for MeSH terms
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases
Metabolic Diseases